GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Healthcare AI Acquisition Corp (NAS:HAIA) » Definitions » ROE %

Healthcare AI Acquisition (Healthcare AI Acquisition) ROE % : 22.98% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Healthcare AI Acquisition ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Healthcare AI Acquisition's annualized net income for the quarter that ended in Dec. 2023 was $1.22 Mil. Healthcare AI Acquisition's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $5.29 Mil. Therefore, Healthcare AI Acquisition's annualized ROE % for the quarter that ended in Dec. 2023 was 22.98%.

The historical rank and industry rank for Healthcare AI Acquisition's ROE % or its related term are showing as below:

HAIA' s ROE % Range Over the Past 10 Years
Min: 3.94   Med: 5.05   Max: 6.15
Current: 4.75

During the past 3 years, Healthcare AI Acquisition's highest ROE % was 6.15%. The lowest was 3.94%. And the median was 5.05%.

HAIA's ROE % is ranked better than
88.04% of 552 companies
in the Diversified Financial Services industry
Industry Median: 0.59 vs HAIA: 4.75

Healthcare AI Acquisition ROE % Historical Data

The historical data trend for Healthcare AI Acquisition's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthcare AI Acquisition ROE % Chart

Healthcare AI Acquisition Annual Data
Trend Dec21 Dec22 Dec23
ROE %
- 6.15 3.94

Healthcare AI Acquisition Quarterly Data
Feb21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.86 -0.42 11.86 30.49 22.98

Competitive Comparison of Healthcare AI Acquisition's ROE %

For the Shell Companies subindustry, Healthcare AI Acquisition's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healthcare AI Acquisition's ROE % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Healthcare AI Acquisition's ROE % distribution charts can be found below:

* The bar in red indicates where Healthcare AI Acquisition's ROE % falls into.



Healthcare AI Acquisition ROE % Calculation

Healthcare AI Acquisition's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=4.328/( (214.339+5.444)/ 2 )
=4.328/109.8915
=3.94 %

Healthcare AI Acquisition's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=1.216/( (5.14+5.444)/ 2 )
=1.216/5.292
=22.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Healthcare AI Acquisition  (NAS:HAIA) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=1.216/5.292
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(1.216 / 0)*(0 / 6.5615)*(6.5615 / 5.292)
=Net Margin %*Asset Turnover*Equity Multiplier
=N/A %*0*1.2399
=ROA %*Equity Multiplier
=N/A %*1.2399
=22.98 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=1.216/5.292
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (1.216 / 1.216) * (1.216 / -0.728) * (-0.728 / 0) * (0 / 6.5615) * (6.5615 / 5.292)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * -1.6703 * N/A % * 0 * 1.2399
=22.98 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Healthcare AI Acquisition ROE % Related Terms

Thank you for viewing the detailed overview of Healthcare AI Acquisition's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Healthcare AI Acquisition (Healthcare AI Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
190 Elgin Avenue, George Town, Grand Cayman, CYM, KY1-9008
Website
Healthcare AI Acquisition Corp is a blank check company.
Executives
Polar Asset Management Partners Inc. 10 percent owner 16 YORK STREET SUITE 2900, TORONTO A6 M5J 0E6
Atticus Ale, Llc 10 percent owner 8 THE GREEN, SUITE 15614, DOVER DE 19901
Zikang Wu director, 10 percent owner, officer: Chief Executive Officer PO BOX 309, UGLAND HOUSE, GRAND CAYMAN E9 KY1-1104
Yuerong Tang director 8 THE GREEN, SUITE 15614, DOVER DE 19901
Hao Tian director 8 THE GREEN, SUITE 15614, DOVER DE 19901
Zixun Jin director 8 THE GREEN, SUITE 15614, DOVER DE 19901
Weiyi Zheng director 8 THE GREEN, SUITE 15614, DOVER DE 19901
Robert Piconi director C/O HEALTHCARE AI ACQUISITION, 7 STANLEY GARDENS, LONDON X0 W112ND
Elizabeth K Weymouth director 55 HUDSON YARDS, 44TH FLOOR, NEW YORK NY 10001
Xavier Flinois director
James William Brooks director 7 STANLEY GARDENS, LONDON X0 W112ND
Patrick Hargutt director, officer: Chief Financial Officer 7 STANLEY GARDENS, LONDON X0 W112ND
Simon Lyall-cottle director, officer: Chief Executive Officer 7 STANLEY GARDENS, LONDON X0 W112ND
Healthcare Ai Acquisition Llc 10 percent owner 7 STANLEY GARDENS, LONDON X0 W112ND
Greg Caswill director C/O HEALTHCARE AI ACQUISITION, 7 STANLEY GARDENS, LONDON X0 W112ND